Expression of cyclins D1, D3 and p27 in thymic epithelial tumors

Interactive Cardiovascular and Thoracic Surgery

Volumn 3, Issue 2, 2004, Pages 245-248

  Zisis, Charalambos ^a,c   Rontogianni, Dimitra ^a   Stefanaki, Kalliopi ^b   Bellenis, Ion ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b 'Agia Sophia' University Children's Hospital   (Greece)

^c NONE   (Greece)

Author keywords

Cell cycle; Cyclin dependent kinase; Cyclin dependent kinase inhibitors; Epithelial tumors; Thymus

Indexed keywords

CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CANCER GRADING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EPITHELIUM TUMOR; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; THYMOMA; THYMUS CANCER; WORLD HEALTH ORGANIZATION;

EID: 2442505504     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.icvts.2003.10.001     Document Type: Conference Paper

References (15)

1. Moller M.B. p27 in cell cycle control and cancer. Leuk Lymphoma. 39:2000;19-27
2. Steel M. Cyclins and cancer: wheels within wheels. Lancet. 343:1994;931-932
3. Taniguchi T., Fujita A., Takahashi S., Uchimaru K., Yoshikawa M., Asano S., Fujita T., Motokura T. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies. Jpn J Cancer Res. 89:1998;159-166
4. Sanchez-Beato M., Camacho F., Martinez-Montero J., Saez A., Villuendas R., Sanchez-Verde L., Garcia J., Piris M. Anomalous high p27/Kip1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/Kip1-cyclin D3 colocalization in tumor cells. Blood. 94:1999;765-772
5. Doglioni C., Chiarelli C., Macri E., Dei Tos A.P., Mezziolaro E., Dalla Palma P., Barbareschi M. Cyclin D3 expression in normal reactive and neoplastic tissues. J Pathol. 185:1998;159-166
6. Lloyd R.V., Erickson L.A., Jin L., Kulig E., Qian X., Cheville J.C., Scheithauer B.W. P27/KIP1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 154:1999;313-323
7. Kanavaros P., Stefanaki K., Rontogianni D., Papalazarou D., Sgantzos M., Arvanitis D., Vamvouka C., Gorgoulis C., Siatitsas I., Agnantis N.J., Bai M. Immunohistochemical expression of p53, p21/waf1, Rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus. Histol Histopathol. 16:2001;1005-1012
8. Rosai J., Sobin L.H. Histological typing of tumors of the thymus. 2nd ed International histologic classification of tumors. 1999;Springer, New York
9. Okumura M., Miyoshi S., Fujii Y., Takeuchi Y., Shiono H., Inoue M., Fukuhara K., Kadota Y., Tateyama H., Eimoto T., Matsuda H. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms. A study of 146 consecutive tumors. Am J Surg Pathol. 25:2001;103-110
10. 1 cyclins. Cell. 73:1993;1059-1065
11. 1 phase progression: cyclin on cue. Cell. 79:1994;551-555
12. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677
13. 1-phase progression. Genes Dev. 13:1999;1501-1512
14. Sun W., Lee D.K., Lee C.C., Kim K. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo. Mol Reprod Dev. 43:1996;414-420
15. Steeg P.S., Abram J.S. Cancer prognostics: post, present and p27. Nature Med. 3:1997;152-154